Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
Figure 2
Serum levels of miR-125b in various rheumatic diseases. (a) Serum levels of mature miR-125b in patients with rheumatoid arthritis (RA, ) or osteoarthritis (OA, ). (b) Serum levels of miR-125b in patients with tumor necrosis factor receptor periodic syndrome (TRAPS), spondyloarthropathies (SpA), and rheumatoid arthritis (RA). miR-125b was quantified by RT-qPCR as described in M&M (–15/group). as determined by Mann-Whitney test.
